White Mistletoe has been used in ancient times for medicinal purposes. For 100 years it has also been proven in integrative oncology. Mistletoe cancer therapy is now available in the U.S.
It blooms in winter, grows spherically on trees, and does not adjust its position to the sun: The “anti-tendency” of mistletoe against natural laws demonstrates similarities to the growth of tumors. Hence, its healing potential for cancer therapy was recognized and the Dutch physician Dr. Ita Wegman developed the first injectable mistletoe preparation in 1918. Today mistletoe therapy is established as a complementary form of therapy in oncology.
Studies show that mistletoe therapy has a positive effect on the patient’s immune system and quality of life and can improve tolerance of standard therapies – such as chemotherapy – without decreasing their efficacy. Mistletoe cancer therapy is appropriate for almost all tumor diseases. You can start using mistletoe therapy at any time – before or after surgery, as well as before, during, or after radiation, chemo, hormonal, or antibody therapies.
You need a doctor for prescribing, initiating and monitoring your mistletoe therapy. The mistletoe extract is injected subcutaneously (under the skin). After briefing by your doctor, you can administer the mistletoe injection yourself, or ask a caregiver to do it.
Around two thirds of all cancer patients use natural medicines and products as a proven complement to conventional therapies because they do not only want to fight their tumors, but also stimulate their self-healing. Mistletoe therapy is established as a beneficial supplement in oncology, and its medical efficacy has been proven in clinical studies.
For more information contact us through our contact form or call 480-535-7868.